Denali Therapeutics logo

Denali Therapeutics Employee Directory

Biotechnology ResearchCalifornia, United States501-1000 Employees

Denali Therapeutics is a mid-sized biotechnology company based in South San Francisco, California, focused on developing therapies capable of crossing the blood-brain barrier. It uses a proprietary TransportVehicle platform to discover, develop, and deliver medicines for neurodegenerative and other serious diseases, including lysosomal storage disorders. The company operates within the biotechnology research sector, pursuing treatments that address central nervous system-related conditions. It is advancing programs such as DNL593, designed to deliver progranulin to the brain using its TransportVehicle technology.

Find Denali Therapeutics employees' phone numbers or email addresses

Denali Therapeutics Global Highlights

Location
Employees

North America
589

Minus sign iconPlus sign icon
  • United States Of America
    588
  • Canada
    1

Europe
22

Minus sign iconPlus sign icon
  • Switzerland
    17
  • France
    2
  • United Kingdom Of Great Britain And Northern Ireland
    1
  • Germany
    1
  • Italy
    1

Asia
4

Minus sign iconPlus sign icon
  • India
    2
  • Turkey
    2

South America
1

Minus sign iconPlus sign icon
  • Brazil
    1

Denali Therapeutics's Leadership

  • Chief Scientific Officer, Head Of Discovery at Denali Therapeutics
    J. L.
    Chief Scientific Officer, Head Of Discovery
  • Vice President International Business (ex-Us) at Denali Therapeutics
    A. C.
    Vice President International Business (ex-Us)
  • Vice President Of Biopharmaceutical Development at Denali Therapeutics
    D. K.
    Vice President Of Biopharmaceutical Development
  • Head Of Development Europe at Denali Therapeutics
    M. O.
    Head Of Development Europe
  • Vice President, Clinical Manufacturing at Denali Therapeutics
    L. F.
    Vice President, Clinical Manufacturing
  • Associate Director, Head Of Quantitative Pharmacology at Denali Therapeutics
    A. M.
    Associate Director, Head Of Quantitative Pharmacology
  • Executive Director, Head Of Biostatistics at Denali Therapeutics
    Y. Z.
    Executive Director, Head Of Biostatistics
  • Associate Director Business Management, Chief Of Staff at Denali Therapeutics
    N. E.
    Associate Director Business Management, Chief Of Staff

Denali Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Operations
  • Engineering
  • Program & Project Management
  • Consultant
  • Other
  • Quality Assurance
  • Human Resources
  • Biotechnology
  • Administrative
  • Business
  • Legal

Contact profiles from Denali Therapeutics

Name
Title
Contact
Location
Last Update
  • Chief Scientific Officer, Head Of Discovery at Denali Therapeutics
    J. L.
    Chief Scientific Officer, Head Of Discovery
    Bay
    Aug 18, 2026
  • Vice President International Business (ex-Us) at Denali Therapeutics
    A. C.
    Vice President International Business (ex-Us)
    Switzerland
    Aug 18, 2026
  • Vice President, Clinical Manufacturing at Denali Therapeutics
    L. F.
    Vice President, Clinical Manufacturing
    Bay
    Jul 01, 2026
  • Associate Director, Head Of Quantitative Pharmacology at Denali Therapeutics
    A. M.
    Associate Director, Head Of Quantitative Pharmacology
    Bay
    Jun 04, 2026
  • Head Of Development Europe at Denali Therapeutics
    M. O.
    Head Of Development Europe
    Switzerland, Zurich
    Jun 04, 2026
  • Executive Director, Head Of Biostatistics at Denali Therapeutics
    Y. Z.
    Executive Director, Head Of Biostatistics
    Bay
    Aug 13, 2026
  • Vice President Of Biopharmaceutical Development at Denali Therapeutics
    D. K.
    Vice President Of Biopharmaceutical Development
    Turkey
    May 31, 2025
  • Associate Director Business Management, Chief Of Staff at Denali Therapeutics
    N. E.
    Associate Director Business Management, Chief Of Staff
    Oct 23, 2024
  • Director, Data Science at Denali Therapeutics
    T. N.
    Director, Data Science
    Switzerland, Zurich
    Aug 25, 2026
  • Senior Director Clinical Operations at Denali Therapeutics
    P. C.
    Senior Director Clinical Operations
    Switzerland, Zurich
    Sep 04, 2026

Frequently Asked Questions

What is Denali Therapeutics known for?

Minus sign iconPlus sign icon
Denali Therapeutics was founded in 2015 and operates in the Biotechnology Research industry. Explore Denali Therapeutics's company overview page for more information.

What is Denali Therapeutics's most common email format?

Minus sign iconPlus sign icon
Denali Therapeutics employees' email format typically follows the pattern of FLast@denalitherapeutics.com. Trying to find reliable and up-to-date employee contact data? Find more Denali Therapeutics email formats with LeadIQ.

How many employees does Denali Therapeutics have currently?

Minus sign iconPlus sign icon
Denali Therapeutics has approximately 589 employees as of August 2026. These team members are located across 4 continents, including North America, Europe and Asia.

Who are Denali Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Denali Therapeutics's key employees include:

  • Chief Scientific Officer, Head Of Discovery: J. L.
  • Vice President International Business (ex-Us): A. C.
  • Vice President Of Biopharmaceutical Development: D. K.
  • Head Of Development Europe: M. O.
  • Vice President, Clinical Manufacturing: L. F.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.